about
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...
Read More
6.15
0.20
(3.36%)
34.8M
XNAS Volume
XNAS 28 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
ImmunityBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..